drugset / Trial / NCT01746004
A Study of LY2157299 Monohydrate in Healthy Volunteers
NaSingle-groupOpen-labelBasic science
Summary
This study involves a single dose of 150 milligram (mg) of radiolabeled LY2157299 monohydrate in healthy participants. The study will determine how the body eliminates the radioactivity and LY2157299 monohydrate. Participants must be healthy surgically sterile or postmenopausal females, or sterile males. This study is approximately 8 to 15 days.
Timeline
- Start
- 2013-01
- Primary completion
- 2013-02
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Galunisertib | Small molecule | 150 mg | Oral |
Indications
No indication recorded.